пиридоксин

пиридоксин Medicine

Overdose

Not identified.

Contraindications

Hypersensitivity.

Incompatibilities

Incompatible with antipsychotic drugs, antidepressants, anxiolitics, barbiturates.

Weakens the action of other drugs that oppress the central nervous system.

Undesirable effects

Allergic reactions.

Therapeutic indications

Hypovitaminosis, peptic ulcer of the stomach and duodenum, hypochrome and microcyte anemia, parkinsonism, chorea, toxicosis of pregnant women, hepatitis, dermatitis, exudative diatosis, neurodermitis, psoriasis.

Pharmacotherapeutic group

  • Vitamins and vitamin-like products

Pharmacodynamic properties

Biotredin® is a tissue exchange regulator, increases mental performance, has a therapeutic effect in an alcohol withdrawal state, and reduces the attraction to alcohol.

L-trionin in the presence of pyridoxin (vitamin B6) breaks up with the formation of aluminocylotis glycin and acetaldehyde, which stimulates braking processes and at the same time oxidative-reduction reactions, breathing processes and synthesis of ATP in cells, due to which the drug is capable of:

- reduce psycho-emotional stress ;

- improve short-term and long-term memory ;

- increase mental performance ;

- normalize the level of endogenous acetaldehyde and thereby reduce the manifestations of alcohol withdrawal symptoms and attraction to alcohol.

The action of the drug Biotredin® manifests itself after 10–20 minutes after sublingual intake.

Pharmacokinetic properties

L-trionin and vitamin B6 fully metabolized to final products. Cumulation of them in the body does not occur.

Special precautions for storage

In a dry, dark place.

Keep out of the reach of children.

Shelf life of the drug Piridoxin3 years.

Do not apply after the expiration date indicated on the package.

Medical application instruction Pyridoxin - instructions for medical use - RU No. P N000357 / 01 from 2011-06-28
Pyridoxin - instructions for medical use - RU No. P N000357 / 01 from 2006-03-10
Pyridoxin - instructions for medical use - RU No. LS-001295 from 2016-04-25
Pyridoxin - instructions for medical use - RU No. LS-001295 from 2006-02-17
Pyridoxin - instructions for medical use - RU No. LS-001903 from 2011-08-15
Pyridoxin - instructions for medical use - RU No. LS-001903 from 2006-08-11

Nature and contents of container

1 ampoule with 1 ml of injection solution contains pyridoxin hydrochloride 0.01 or 0.05 g; in a cardboard box of 10 pcs.

1 tablet - 0.01 g; in banks of 10 pieces., in a cardboard pack of 1 bank.

Nosological classification (ICD-10)

  • D50 Iron deficiency anemia
  • E53.1 Lack of pyridoxin
  • G21 Secondary Parkinsonism
  • G25 Other extrapyramid and motor disorders
  • K25 Vastric ulcer
  • K26 Twin bowel ulcer
  • K73 Chronic hepatitis not classified in other headings
  • L20 Atopic dermatitis
  • L30.9 Unspecified dermatitis
  • L40 Psoriasis
  • O14.9 Preeclampsia [petroleum therapy] unspecified

Qualitative and quantitative composition

Pyridoxine Hydrochloride

Dosage (Posology) and method of administration

V / m, with parkinsonism - 0.1 g / day; for anemia - 1 ml 2 times a week.

Inside, for adults - 0.02–0.03 g 1–2 times a day, for children - 0.002 g / day. The course is 1-2 months.

ATC - Anatomical and therapeutic chemical classification

A11HA02 Pyridoxin (vitamin B6)